Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
The preparation of this study was supported in part by NIH/NCi Cancer Center Support Grant No. P30CA008748 to Memorial Sloan Kettering Cancer Center, and this study was presented in poster format at the 23rd Annual Meeting of the American Society of Breast Surgeons, 6–10 April 2022, Las Vegas, NV. Dr. Monica Morrow has received honoraria from Roche and Exact Sciences. All other authors have no relevant conflicts of interest to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Pilewskie, M., Sevilimedu, V., Eroglu, I. et al. ASO Visual Abstract: How Often Do Sentinel Lymph Node Biopsy Results Affect Adjuvant Therapy Decisions Among Postmenopausal Women with Early-Stage HR+/HER2− Breast Cancer in the Post-RxPONDER Era?. Ann Surg Oncol 29, 6274–6275 (2022). https://doi.org/10.1245/s10434-022-12246-0
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-022-12246-0